Trinity Biotech ADR buy StockNews.com
Start price
15.10.23
/
50%
€0.49
Target price
15.10.24
-
Performance (%)
-13.82%
End price
16.10.24
-
Summary
This prediction is currently being closed. The price of Trinity Biotech ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.82%. StockNews_com has a follow-up prediction for Trinity Biotech ADR, but this time predicts that Trinity Biotech ADR is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Trinity Biotech ADR | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten